z-logo
open-access-imgOpen Access
Assessment of the feed additive consisting of Levilactobacillus brevis (formerly Lactobacillus brevis ) DSM 12835 EU for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG )
Author(s) -
Bampidis Vasileios,
Azimonti Giovanna,
Bastos Maria de Lourdes,
Christensen Henrik,
Dusemund Birgit,
Fašmon Durjava Mojca,
Kouba Maryline,
LópezAlonso Marta,
López Puente Secundino,
Marcon Francesca,
Mayo Baltasar,
Pechová Alena,
Petkova Mariana,
Ramos Fernando,
Sanz Yolanda,
Villa Roberto Edoardo,
Woutersen Ruud,
Saarela Maria,
Galobart Jaume,
Gregoretti Lucilla,
Revez Joana,
Vettori Maria Vittoria,
Brozzi Rosella
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6900
Subject(s) - authorization , context (archaeology) , european commission , lactobacillus brevis , feed additive , animal species , food science , biology , microbiology and biotechnology , european union , business , lactic acid , lactobacillus plantarum , computer science , zoology , bacteria , computer security , international trade , genetics , paleontology , broiler
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed ( FEEDAP ) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of Levilactobacillus brevis (formerly Lactobacillus brevis ) DSM 12835 as a technological additive for all animal species. The additive aims to improve the production of silage and is authorised without a minimum inclusion level. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence to lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concluded that the additive remains safe for all animal species, consumers and the environment under the authorised conditions of use. Regarding user safety, L. brevis DSM 12835 is not irritant to skin and eyes but is considered a skin and respiratory sensitiser. There was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here